These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23273051)

  • 1. Vasopressin and terlipressin in adult vasodilatory shock.
    Polito A; Parisini E; Ricci Z; Picardo S; Annane D
    Crit Care; 2012 Dec; 16(6):470; author reply 470. PubMed ID: 23273051
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin vs. terlipressin in the treatment of shock states.
    Singer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin analogs in portal hypertension: different molecules but similar questions.
    Blei AT
    Hepatology; 1986; 6(1):146-7. PubMed ID: 3510949
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient with a sudden drop in blood pressure.
    Oliver JA; Landry DW
    Crit Care Med; 2003 Jan; 31(1):326-7. PubMed ID: 12545047
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Terlipressin in the treatment of septic shock: the earlier the better"?
    Morelli A; Ertmer C; Westphal M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):317-21. PubMed ID: 18683477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis.
    Polito A; Parisini E; Ricci Z; Picardo S; Annane D
    Intensive Care Med; 2012 Jan; 38(1):9-19. PubMed ID: 22127480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terlipressin infusion in catecholamine-resistant shock.
    Jolley DH; De Keulenaer BL; Potter A; Stephens DP
    Anaesth Intensive Care; 2003 Oct; 31(5):560-4. PubMed ID: 14601280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.
    Dünser MW; Mayr AJ; Wenzel V; Hasibeder WR
    Intensive Care Med; 2004 Oct; 30(10):1982; author reply 1983. PubMed ID: 15278269
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
    Leone M; Martin C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive drugs in the intensive care unit.
    Holmes CL
    Curr Opin Crit Care; 2005 Oct; 11(5):413-7. PubMed ID: 16175026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury.
    Meyer S; Gottschling S; Gortner L
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):957. PubMed ID: 17635407
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasopressin analogues in the treatment of shock states: potential pitfalls.
    Ertmer C; Rehberg S; Westphal M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):393-406. PubMed ID: 18683484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis.
    Masarwa R; Paret G; Perlman A; Reif S; Raccah BH; Matok I
    Crit Care; 2017 Jan; 21(1):1. PubMed ID: 28057037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of vasopressin in pediatric patients.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian Pediatr; 2012 Apr; 49(4):297-305. PubMed ID: 22565074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.